Garuda Indonesia (Persero) Tbk. vs Brigit Biofarmaka Teknologi Tbk. — how do they compare? Garuda Indonesia (Persero) Tbk. trades at Rp52 (market cap 21.58T, 20.15M 24h volume), while Brigit Biofarmaka Teknologi Tbk. trades at Rp248 (market cap 167.37B, 96.7K 24h volume). The key difference: Garuda Indonesia (Persero) Tbk. is far larger — about 128.9× Brigit Biofarmaka Teknologi Tbk.'s market cap, and Garuda Indonesia (Persero) Tbk. is more actively traded (20.15M versus 96.7K). Which is the better fit depends on your goals.
| GIAA | OBAT | |
|---|---|---|
Market Cap | 21.58T | 167.37B |
Volume | 20.15M | 96.7K |
Lot | 201.5K | 967 |
Turnover | 1.05B | 23.82M |
Average Price | 52.18 | 246.34 |
Value | 1.05B | 23.82M |
Indicative Equilibrium Price | 52 | 248 |
Indicative Equilibrium Volume | 7.53K | 41 |
Trailing returns across standard periods
Latest headlines on both assets
The Company is a state-owned airline of the republic of Indonesia and commercial air transportation service provider for passenger, cargo, and other services related to air transportation in Indonesia. The Company also provides services related aviation services, including repairs, maintenance and overhaul (MRO), aircraft, ground services, air tickets reservation and provision, and in fight catering, as well as travel services, tourism and hospitality.The Company was established on March 31, 1950 with the name of Garuda Indonesian Airways NV domiciled in Central Jakarta. In accordance with government regulations, in 1975 the company changed its form a Limited Liability Company (Persero) PT Garuda Indonesian Airways.
Read more on GIAA →PT. Brigit Biofarmaka Teknologi Tbk. (the Company) was established based on Notarial Deed No. 103 dated December 14, 2015 of Yoerista Arya Megasari, S.H., M.Kn., Notary in Sukoharjo. The company starts production commercially in 2018.
Read more on OBAT →